NEWSROOM
News & Stories
Newsroom
Press Releases
Agendia Study Demonstrates MammaPrintยฎ and BluePrintยฎ Capture Full Spectrum of Early Breast Cancer Biology, Providing Opportunity for Highly Individualized Treatment
New analysis in peer-reviewed journal Genes, Chromosomes and Cancer further establishes that MammaPrint and BluePrint both comprehensively represent and capture the 10 hallmarks of cancer in early-stage breast cancer Study validates genomic basis of Read More
Agendia to Provide First Digital MammaPrint Capability to Brazil
AI solution will expand Agendiaโs testing platform in the Brazilian breast cancer market Digital MammaPrint offers fast turnaround time to molecular diagnostics, delivering actionable information to physicians treating patients with breast cancer IRVINE, CALIF., U.S., Read More
Agendia Partners with Illumina to Expand Genomic Testing in Breast Cancer Care
Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing, to bring improved insights to patients with breast cancer globally IRVINE, CALIF., U.S., and AMSTERDAM, NETHERLANDS โ January 10, 2022 โ Agendia, Read More